| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 31.607 | 29.184 | 28.313 | 27.728 | 30.035 | 41.225 |
| Total Income - EUR | - | - | - | - | 31.607 | 31.187 | 28.329 | 27.728 | 30.035 | 41.225 |
| Total Expenses - EUR | - | - | - | - | 12.849 | 8.938 | 8.690 | 15.587 | 16.561 | 17.114 |
| Gross Profit/Loss - EUR | - | - | - | - | 18.758 | 22.249 | 19.639 | 12.142 | 13.474 | 24.111 |
| Net Profit/Loss - EUR | - | - | - | - | 17.810 | 21.374 | 18.806 | 11.427 | 13.210 | 22.899 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Anghele Răzvan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 1.952 | 2.146 | 1.670 | 8.039 | 11.167 |
| Current Assets | - | - | - | - | 17.546 | 33.904 | 36.008 | 26.860 | 18.175 | 37.219 |
| Inventories | - | - | - | - | 0 | 0 | 616 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.661 | 2.129 | 13.491 | 10.405 | 31.554 |
| Cash | - | - | - | - | 17.546 | 32.243 | 33.263 | 13.368 | 7.770 | 5.664 |
| Shareholders Funds | - | - | - | - | 17.332 | 34.251 | 18.855 | 11.476 | 13.329 | 23.018 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 214 | 1.588 | 19.299 | 17.054 | 12.884 | 25.367 |
| Income in Advance | - | - | - | - | 0 | 16 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Anghele Răzvan S.r.l.